| Nathan C Dean, MD | |
|
333 S 900 E, Salt Lake City, UT 84102-2310 | |
| (801) 535-8163 | |
| (801) 355-4011 |
| Full Name | Nathan C Dean |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 47 Years |
| Location | 333 S 900 E, Salt Lake City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063437770 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 163339-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Intermountain Medical Center | Murray, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
China Medicine Corporation announced today that it obtained a patent from Australia Patent Office for recombinant Aflatoxin Detoxifizyme (rADTZ). The patent is valid through January 13, 2025.
A new report from MacMillan Cancer Support has revealed that cancer diagnosis is now one of the most common events in people's lives, with new cases being more common each year in the UK than marriage.
Adding to mounting evidence of COVID-19's disproportionate impact on some U.S. communities, a new analysis of hospitalization rates from the University of Minnesota shows Black, Hispanic, American Indian and Alaskan Native populations in the United States are significantly more likely to be hospitalized due to COVID-19 than whites.
VCA Antech, Inc., a leading animal healthcare company in the United States and Canada, today reported financial results for the fourth quarter ended December 31, 2013, as follows: revenue increased 4.1% to $435.5 million and gross profit increased 6.9% to $87.5 million; operating income increased 155.0% to $45.9 million; net income increased 142.6% to $24.7 million and diluted earnings per common share increased 142.4% to $0.28.
› Verified 2 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
China Medicine Corporation announced today that it obtained a patent from Australia Patent Office for recombinant Aflatoxin Detoxifizyme (rADTZ). The patent is valid through January 13, 2025.
A new report from MacMillan Cancer Support has revealed that cancer diagnosis is now one of the most common events in people's lives, with new cases being more common each year in the UK than marriage.
Adding to mounting evidence of COVID-19's disproportionate impact on some U.S. communities, a new analysis of hospitalization rates from the University of Minnesota shows Black, Hispanic, American Indian and Alaskan Native populations in the United States are significantly more likely to be hospitalized due to COVID-19 than whites.
VCA Antech, Inc., a leading animal healthcare company in the United States and Canada, today reported financial results for the fourth quarter ended December 31, 2013, as follows: revenue increased 4.1% to $435.5 million and gross profit increased 6.9% to $87.5 million; operating income increased 155.0% to $45.9 million; net income increased 142.6% to $24.7 million and diluted earnings per common share increased 142.4% to $0.28.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nathan C Dean, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 535-8163 | Nathan C Dean, MD 333 S 900 E, Salt Lake City, UT 84102-2310 Ph: (801) 535-8163 |
News Archive
China Medicine Corporation announced today that it obtained a patent from Australia Patent Office for recombinant Aflatoxin Detoxifizyme (rADTZ). The patent is valid through January 13, 2025.
A new report from MacMillan Cancer Support has revealed that cancer diagnosis is now one of the most common events in people's lives, with new cases being more common each year in the UK than marriage.
Adding to mounting evidence of COVID-19's disproportionate impact on some U.S. communities, a new analysis of hospitalization rates from the University of Minnesota shows Black, Hispanic, American Indian and Alaskan Native populations in the United States are significantly more likely to be hospitalized due to COVID-19 than whites.
VCA Antech, Inc., a leading animal healthcare company in the United States and Canada, today reported financial results for the fourth quarter ended December 31, 2013, as follows: revenue increased 4.1% to $435.5 million and gross profit increased 6.9% to $87.5 million; operating income increased 155.0% to $45.9 million; net income increased 142.6% to $24.7 million and diluted earnings per common share increased 142.4% to $0.28.
› Verified 2 days ago
Dr. Mehmet Akkaya, M.D Pulmonary Disease Medicare: Medicare Enrolled Practice Location: University Of Utah Hospital Cardiology, 3o N,1900 E, Rm:4a100, Salt Lake City, UT 84132 Phone: 801-505-1689 | |
Dr. Willard Dere, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 500 Foothill Blvd, Salt Lake City, UT 84148 Phone: 801-582-1565 | |
Megan Meier, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Joel Money, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Mchale O. Anderson, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4a100, Salt Lake City, UT 84132 Phone: 801-587-2451 | |
Siddharth K. Iyengar, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4c116, Salt Lake City, UT 84132 Phone: 801-581-7606 | |
Taryn A. Young, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 5121 S Cottonwood St, Salt Lake City, UT 84107 Phone: 801-507-4384 Fax: 801-507-4398 |